PIM
EW icon

Partner Investment Management’s Edwards Lifesciences EW Stock Holding History

Partner Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,000
Closed -$574K – 87
2019
Q1 		$574K Buy
+9,000
New +$514K 0.66% 54

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Partner Investment Management's EW Position: Q4 2019 in Review

Partner Investment Management reduced its Edwards Lifesciences (EW) stake by 79% in Q4 2019, selling an estimated $687K and leaving 2,364 shares worth $184K. The position accounts for 1.32% of the portfolio, ranked #29.

Partner Investment Management first reported a position in EW in Q4 2014 and has held it in 21 quarters since. The position peaked at $4.59M in Q4 2014. 1,093 funds tracked by Wall St. Rank hold EW as of Q4 2019.

  • Partner Investment Management held 2,364 shares of Edwards Lifesciences worth $184K as of Q4 2019.
  • Partner Investment Management sold 8,793 Edwards Lifesciences shares in Q4 2019, an estimated $687K.
  • Edwards Lifesciences made up 1.32% of Partner Investment Management's portfolio in Q4 2019, its #29 holding.
  • Partner Investment Management first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 21 quarters since.
  • Partner Investment Management's Edwards Lifesciences position peaked at $4.59M in Q4 2014.
  • 1,093 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.